The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.

The bill for fiscal year 2019 increases allocations for NSF, FDA, and others above 2018 levels.

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

From missing paychecks to delayed grants to canceled travel, federal research is feeling the sting.

The ongoing stalemate over the federal budget has forced one-quarter of the US government to begin a second week of closure.

The agency cites safety concerns with customers of Genetech who reported getting E. coli infections and sends letters to other stem cell companies reminding them to follow the rules.

While farmers have the green light to grow the genetically engineered plant, FDA approval is still needed before the seeds are sold as food.

Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.